Nipro Corp

5FA

Company Profile

  • Business description

    Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm is divided into three segment: Medical segment sells medical devices related to injections and infusions, artificial organs, high-performance devices, and dialysis, as well as pharmaceuticals related to diabetes, generics, and kit formulations in Japan and overseas; Pharmaceutical segment handles the consignment sales of pharmaceuticals from pharmaceutical companies, including containers for kit formulations; and Pharmaceutical Packaging handles glass for medical use in Japan, including glass for vials and ampoules, and glassware. Nipro generates the majority of its revenue in Japan, while it also has its presence in America, Europe and Asia.

  • Contact

    3-26 Senrioka Shinmachi
    Settsu City
    Osaka566-8510
    JPN

    T: +81 663106804

    http://www.nipro.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 March 2027

    Employees

    39,763

Stocks News & Analysis

stocks

ASX major bank drives strong quarterly profit

Profit momentum remains robust yet shares overvalued.
stocks

Ask the analyst: What to expect in earnings season?

The key metrics that matter this earnings season.
stocks

ASX healthcare share remains undervalued ahead of earnings

Margin recovery remains the key driver for this ASX healthcare share.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,063.8036.200.40%
CAC 408,406.0633.780.40%
DAX 4025,361.03262.031.04%
Dow JONES (US)52,210.08262.830.51%
FTSE 10010,781.7545.520.42%
HKSE25,207.18243.950.98%
NASDAQ24,932.0843.74-0.18%
Nikkei 22564,931.19320.040.50%
NZX 50 Index13,797.7452.95-0.38%
S&P 5007,413.181.200.02%
S&P/ASX 2008,894.0036.100.41%
SSE Composite Index3,858.2544.051.15%

Market Movers